Clinical Trial Update: Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating radiation therapy and cisplatin with or without cetuximab in stage III/IV head and neck cancer; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• Radiation therapy

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Head and Neck Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-12-21